1. Short title This Act may be cited as the Access to Breast Cancer Diagnosis Act of 2020 . 2. Requiring parity in cost-sharing and treatment limitations with respect to diagnostic and screening examinations for breast cancer (a) In general Section 2719A of the Public Health Service Act ( 42 U.S.C. 300gg–19a ) is amended by adding at the end the following new subsection: (e) Diagnostic and screening examinations for breast cancer parity (1) In general In the case of a group health plan, or a health insurance issuer offering group or individual health insurance coverage, that provides benefits with respect to a diagnostic examination for breast cancer furnished to an individual enrolled under such plan or such coverage, such plan or such coverage shall ensure that— (A) the cost-sharing requirements applicable to such examination for such individual are no less favorable than such requirements applicable to a screening examination for breast cancer for such individual; and (B) the treatment limitations applicable to such diagnostic examination for breast cancer for such individual are no less favorable than such limitations applicable to a screening examinations for breast cancer for such individual. (2) Restriction on certain changes A group health plan or health insurance issuer may not, for the sole purpose of complying with paragraph (1), increase cost-sharing requirements with respect to screening examinations for breast cancer. (3) Construction Nothing in this subsection shall be construed— (A) to require the use of diagnostic examinations for breast cancer as a replacement for screening examinations for breast cancer; (B) to prohibit a group health plan or health insurance issuers from requiring prior authorization or imposing other appropriate utilization controls in approving coverage for any screening or diagnostic imaging